Eliezer Katz

Technik-/Wissenschafts-/F&E-Leiter bei ELEDON PHARMACEUTICALS, INC.

Health Technology

Commercial Services

Consumer Services

Aktive Beziehungen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Steven Perrin	M	59	ELEDON PHARMACEUTICALS, INC.	4 Jahre
Bryan Smith	M	45	ELEDON PHARMACEUTICALS, INC.	3 Jahre
Keith Katkin	M	52	ELEDON PHARMACEUTICALS, INC.	7 Jahre
Walter Ogier	M	67	ELEDON PHARMACEUTICALS, INC.	4 Jahre
John McBride	M	72	ELEDON PHARMACEUTICALS, INC.	7 Jahre
David-Alexandre Gros	M	51	ELEDON PHARMACEUTICALS, INC.	4 Jahre
June Lee	M	58	ELEDON PHARMACEUTICALS, INC.	4 Jahre
Jan Hillson	M	71	ELEDON PHARMACEUTICALS, INC.	3 Jahre
Paul Little	M	60	ELEDON PHARMACEUTICALS, INC.	3 Jahre
Allan Kirk	M	62	ELEDON PHARMACEUTICALS, INC.	1 Jahre
Michael S. Curtis	M	-	eGenesis, Inc. eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.	2 Jahre
James Robinson	M	54	ELEDON PHARMACEUTICALS, INC.	1 Jahre
David Hovland	M	-	ELEDON PHARMACEUTICALS, INC.	3 Jahre
John Herberger	M	-	ELEDON PHARMACEUTICALS, INC.	2 Jahre

Mehr sehen

Beziehungen zu mehreren Unternehmen

Name	Geschlecht	Alter	Unternehmensverbindungen	Zusammenarbeit
Christian Nolet	M	67	VIELA BIO, INC.	2 Jahre
Matthew J. Pietras	M	-	VIELA BIO, INC.	2 Jahre
Andreas Wicki	M	64	VIELA BIO, INC.	3 Jahre
Xiao Meng Tong	M	50	VIELA BIO, INC.	2 Jahre
Pascal Soriot	M	64	VIELA BIO, INC.	1 Jahre
Timothy Gray	M	54	Medimmune, Inc.	5 Jahre
Jim Kastenmayer	M	52	VIELA BIO, INC.	1 Jahre
Mitchell Chan	M	43	VIELA BIO, INC.	3 Jahre
Harriet Robinson	M	86	University of Massachusetts Medical Center	9 Jahre
Pauline Callinan	M	-	Medimmune, Inc.	4 Jahre
Soraya Madani	M	-	VIELA BIO, INC.	2 Jahre
Aaron Ren	M	46	VIELA BIO, INC.	2 Jahre
Jörn Drappa	M	60	Medimmune, Inc.	7 Jahre
Jacques Suzanne	F	53	VIELA BIO, INC.	1 Jahre
Norman Michael Greenberg	M	64	Medimmune, Inc.	3 Jahre
Steven Projan	M	72	Medimmune, Inc.	8 Jahre
NgocDiep Le	M	56	Medimmune, Inc.	2 Jahre
Yi Hong Yao	M	57	Medimmune, Inc.	4 Jahre
Robert Steven Sikorski	M	-	Medimmune, Inc.	4 Jahre
Jeffrey D. Bornstein	M	-	ELEDON PHARMACEUTICALS, INC.	2 Jahre
Krishna Kandarpa	M	73	University of Massachusetts Medical Center	7 Jahre
Laura Alessio	F	-	eGenesis, Inc. eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA.	1 Jahre

Land	Beziehungen	% des Gesamten
Vereinigte Staaten	36	100,00%

Alter der Beziehungen

Aktive

Vergangene

Herr

Frau

Aufsichtsräte

Führungskräfte

Ursprung der Beziehungen